The potential risks of C-C chemokine receptor 5-edited babies in bone development

被引:0
|
作者
Yong Xie [1 ]
Shaohua Zhan [2 ]
Wei Ge [2 ]
Peifu Tang [1 ]
机构
[1] Department of Orthopedics,Chinese PLA General Hospital
[2] State Key Laboratory of Medical Molecular Biology and Department of Immunology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences
基金
中国国家自然科学基金;
关键词
CCR; The potential risks of C-C chemokine receptor 5-edited babies in bone development;
D O I
暂无
中图分类号
R714.8 [];
学科分类号
摘要
INTRODUCTION Hutter et al.1first reported that a bone marrow transplant using stem cells derived from a donor with homozygous CCR5 delta32gene mutation remained HIV-positive but virus-free (below the limits of detection) after halting antiretroviral therapy.Since this observation in 2009,mutation of the CCR5 gene has become an important target in the prevention and treatment of HIV infection.
引用
收藏
页码:118 / 121
页数:4
相关论文
共 50 条
  • [31] Role Of The C-C Motif Chemokine Ligand 5 (CCL5) And Its Receptor, C-C Motif Chemokine Receptor 5 (CCR5) In The Genesis Of Aldosterone-induced Hypertension, Vascular Dysfunction, And End- organ Damage
    Costa, Rafael
    Alves, Juliano
    Santos, Debora
    Awata, Wanessa
    Singh, Shubhnita
    Bruder-Nascimento, Ariane
    Ho, Jacqueline
    Bruder, Thiago
    HYPERTENSION, 2023, 80
  • [32] Cloning and functional characterization of the rabbit C-C chemokine receptor 2
    Lu, DS
    Yuan, XJ
    Evans, RJ
    Pappas, AT
    Wang, H
    Su, EW
    Hamdouchi, C
    Venkataraman, C
    BMC IMMUNOLOGY, 2005, 6 (1)
  • [33] The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine
    Beck, Tyler C.
    Beck, Kyle R.
    Holloway, Calvin B.
    Hemings, Richard A., Jr.
    Dix, Thomas A.
    Norris, Russell A.
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [34] Cloning and functional characterization of the rabbit C-C chemokine receptor 2
    Deshun Lu
    Xiu-juan Yuan
    Robert J Evans
    Amy T Pappas
    He Wang
    Eric W Su
    Chafiq Hamdouchi
    Chandrasekar Venkataraman
    BMC Immunology, 6
  • [35] C-C Chemokine Receptor 1 Expression in Human Hematolymphoid Neoplasia
    Anderson, Matthew W.
    Zhao, Shuchun
    Ai, Weiyun Z.
    Tibshirani, Robert
    Levy, Ronald
    Lossos, Izidore S.
    Natkunam, Yasodha
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 133 (03) : 473 - 483
  • [36] C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload
    Wang, Xiaomin
    Li, Wei
    Yue, Qiang
    Du, Wei
    Li, Yongming
    Liu, Fu
    Yang, Liu
    Xu, Lijuan
    Zhao, Ruiping
    Hu, Jiang
    MOLECULAR MEDICINE REPORTS, 2021, 23 (01)
  • [37] Novel drug classes: entry inhibitors [enfuvirtide, chemokine (C-C motif) receptor 5 antagonists]
    McKinnell, James A.
    Saag, Michael S.
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (06) : 513 - 517
  • [38] Targeting C-C Chemokine Receptor 5: Key to Opening the Neurorehabilitation Window After Ischemic Stroke
    Feng, Yi-Qi
    Xu, Zhen-Zhen
    Wang, Yan-Ting
    Xiong, Yue
    Xie, Wanli
    He, Yu-Yao
    Chen, Lu
    Liu, Guo-Yang
    Li, Xia
    Liu, Jie
    Wu, Qingping
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [39] Decreased pain responses of C-C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli
    Lee, Yong Kyoung
    Choi, Dong-Young
    Jung, Yu-Yeon
    Yun, Young Won
    Lee, Beom Jun
    Han, Sang Bae
    Hong, Jin Tae
    NEUROPHARMACOLOGY, 2013, 67 : 57 - 65
  • [40] C-C motif chemokine ligand 2/C-C receptor 2 is associated with glioma recurrence and poor survival
    Yang, Qiuan
    Zhang, Junpeng
    Zhang, Xin
    Miao, Lifeng
    Zhang, Wei
    Jiang, Zheng
    Zhou, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)